Search

Your search keyword '"McGarvey, Lorcan P. A."' showing total 272 results

Search Constraints

Start Over You searched for: Author "McGarvey, Lorcan P. A." Remove constraint Author: "McGarvey, Lorcan P. A."
272 results on '"McGarvey, Lorcan P. A."'

Search Results

5. M2 Muscarinic Receptor-Dependent Contractions of Airway Smooth Muscle are Inhibited by Activation of β-Adrenoceptors.

10. Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined Subgroups

11. Objective and Subjective Measurement of Cough in Asthma: A Systematic Review of the Literature

13. Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials

14. Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK

15. Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant

16. Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial

17. British Thoracic Society Clinical Statement on chronic cough in adults

19. P2X3-Receptor Antagonists as Potential Antitussives: Summary of Current Clinical Trials in Chronic Cough

22. Consensus goals and standards for specialist cough clinics: the NEUROCOUGH international Delphi study

25. Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks

26. Reply to Weinberger

33. Large scale clinical trials: lessons from the COVID-19 pandemic

35. Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker‐high and ‐low severe asthma

41. Raised FeNO in optimally-treated severe asthma identifies persistent eosinophilic chemotactic pull towards the airway

42. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

43. Somatic Cough Syndrome (Previously Referred to as Psychogenic Cough) and Tic Cough (Previously Referred to as Habit Cough) in Adults and Children

44. Functional expression of NaV1.7 channels in freshly dispersed mouse bronchial smooth muscle cells.

46. Non-typeable Haemophilus influenzae chronic colonization in chronic obstructive Pulmonary disease (COPD)

Catalog

Books, media, physical & digital resources